Research Applications Amylin receptor signaling research Combination metabolic studies (amylin + GLP-1) Satiety and appetite regulation investigations Gastric emptying and GI motility research Obesity biology and body weight regulation Quality Specifications Purity: 98% (HPLC verified) Compound: Cagrilintide Molecular Weight: ~3.9 kDa Form: Lyophilized powder Origin: Made in the USA Testing: Third-party tested in a US laboratory Storage: -20C, protect from light COA: Batch-specific, ISO-accredited laboratory Frequently Asked Questions Q: Why combine Cagrilintide with GLP-1 agonists
The composition of the mobile phase is gradually changed (a "gradient") to become more non-polar, which systematically "washes" the molecules off the column, starting with the least retained and ending with the most retained
FDA Advisors Recommend Compounding Access for Several High-Profile Peptides FDA peptide compounding update the peptide industry may be entering a new chapter
This final rule provides descriptions of the requirements that we would mandate, identifies the payment methodology to be tested, and presents rationales for our decisions and, where relevant, alternatives that we considered
Measure alignment can also reduce confusion, burden, and operational complexity for ASM participants by limiting the need for ASM participants to implement different specifications for potentially similar or related measures
This product is intended strictly for laboratory research and scientific investigation purposes only.The peptides and peptide blends are not approved for human or veterinary use
